Live

compounded drugs

2 articles

Eli Lilly Warns of Unknown Impurity in Compounded Weight Loss Drugs

Benzinga

Benzinga·Mar 12·Vandana Singh

Eli Lilly Warns of Unknown Impurity in Compounded Weight Loss Drugs

Eli Lilly warns of unidentified impurity in compounded tirzepatide weight loss drugs mixed with vitamin B12, urging FDA recalls and stricter oversight.

LLYweight loss drugsZepbound

Hims & Hers Surges 40% on Novo Nordisk Deal, But Valuation Concerns Linger

The Motley Fool

The Motley Fool·Mar 9·Geoffrey Seiler

Hims & Hers Surges 40% on Novo Nordisk Deal, But Valuation Concerns Linger

Hims & Hers surges 40% after Novo Nordisk partnership resolves litigation, enabling authorized distribution of Wegovy and Ozempic. Stock trades under 20x forward P/E.

NVOHIMSGLP-1 drugstelemedicine